Your session is about to expire
← Back to Search
Behavioral Intervention
UNTIRE App for Cancer-Related Fatigue
N/A
Waitlist Available
Led By Nina N Grenon, DNP, AOCN
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
Study Summary
This trial is looking into if the Untire app can help manage CRF and if it's easy to use.
Who is the study for?
This trial is for adults over 18 with recurrent colorectal cancer who are currently undergoing treatment. Participants must own a smartphone or iPad, be able to read and speak English at a basic level, and experience fatigue related to their cancer.Check my eligibility
What is being tested?
The study is testing the 'Untire' app, designed as a digital tool to help manage Cancer Related Fatigue (CRF) in patients with colorectal cancer. The research will assess if the app is user-friendly and effective in reducing fatigue.See study design
What are the potential side effects?
Since this trial involves using an app for managing fatigue, there aren't typical medication side effects. However, users may experience frustration or stress if they find the technology challenging or if they do not see improvements in their fatigue.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Enrollment Rate
Secondary outcome measures
CSQ-I Score
Other outcome measures
The Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-F) Ratings
Trial Design
1Treatment groups
Experimental Treatment
Group I: UNTIRE AppExperimental Treatment1 Intervention
At baseline meeting participants will answer questionnaires and be introduced and instructed on self-managed use of Untire app treatment program.
Participants will then have check in meetings assessing app usage and progress on weeks 4, 8 and 12 post baseline, then a final check-in 6 months post baseline.
Find a Location
Who is running the clinical trial?
Dana-Farber Cancer InstituteLead Sponsor
1,078 Previous Clinical Trials
340,812 Total Patients Enrolled
Nina N Grenon, DNP, AOCNPrincipal InvestigatorDana-Farber Cancer Institute
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I am taking dexamethasone for reasons other than nausea control.I am currently receiving treatment for cancer that has spread.I have been diagnosed with a type of colon cancer that has spread.I am taking Ritalin for cancer-related fatigue.
Research Study Groups:
This trial has the following groups:- Group 1: UNTIRE App
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is participation in this trial accepting new enrollees at present?
"Based upon the info found on clinicaltrials.gov, this specific trial is no longer accepting patients into its ranks. First posted in January of 2023 and last updated in December 2022, 1279 other trials are currently recruiting participants to explore potential treatments for various illnesses."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger